Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5

Introduction Thus far, with the first 3 parts of this five-part series, we’ve examined 60% (18 of 30) of the 30 stocks in the Dow Jones Industrial Average.  What we found so far were that the majority of these constituents are currently overvalued or at least fully valued.  Finally, with this Part 4, we will Read more about Why Are These 6 Dow Stocks Fairly Valued?: Part 4 of 5[…]

Dissecting the Dow: 21 of the 30 Dow Stocks are Undervalued, 6 are Fairly Valued, and Only 3 Appear Overvalued

Introduction In this final segment, we will cover the 10 poorest performing DJIA stocks since 1995.  In part one which covered the best 10 performing DJIA stocks; we saw a group of companies that could best be described as consistent above-average earnings generators.  Consequently, it makes sense that they were the best performers since we Read more about Dissecting the Dow: 21 of the 30 Dow Stocks are Undervalued, 6 are Fairly Valued, and Only 3 Appear Overvalued[…]

6 High Yield Pharmaceutical Companies: Do They Justify the Risk?

Introduction Today Investors are keenly focused on income while simultaneously very risk averse.This current behavior brings with it a level of frustration.The appetite for yield is high precisely at a time when yields on the traditionally safest investments like bonds and CDs, etc. are at historic lows.On the other hand, dividend yields on many blue-chip Read more about 6 High Yield Pharmaceutical Companies: Do They Justify the Risk?[…]